Distance Learning and Telemedicine Grants–Opioid.


Funding Opportunity ID: 312936
Opportunity Number: RUS-19-01-DLT
Opportunity Title: Distance Learning and Telemedicine Grants–Opioid.
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Category Explanation:
CFDA Number(s): 10.855
Eligible Applicants: State governments
Special district governments
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Small businesses
Additional Information on Eligibility:
Agency Code: USDA-RUS
Agency Name: Department of Agriculture
Utilities Programs
Posted Date: Feb 14, 2019
Close Date: Apr 15, 2019
Last Updated Date: Feb 14, 2019
Award Ceiling: $500,000
Award Floor: $50,000
Estimated Total Program Funding: $10,000,000
Expected Number of Awards: 40
Description: Authorized by 7 U.S.C. §950aaa, the DLT Program provides financial assistance to enable and improve distance learning and telemedicine services in rural areas. DLT grant funds support the use of telecommunications-enabled information, audio and video equipment, and related advanced technologies by students, teachers, medical professionals, and rural residents. These grants are intended to increase rural access to education, training, and health care resources that are otherwise unavailable or limited in scope. In March 2018, Congress explicitly appropriated an additional $20 million for the DLT Program in the Consolidated Appropriations Act, 2018, Pub. L. 115-141, § 775 (2018) "to help address the opioid epidemic in rural America." Approximately half of this funding was awarded in FY 2018 to DLT projects that had opioid treatment as their primary purpose. For the remaining funds, the Agency is soliciting applications that specifically support treatment for, and prevention of, opioid use disorder in rural areas. Applications submitted under this announcement should address how they will strengthen local capacity to address one or more of the following focus areas: 1. Prevention—for example, educating community members and care providers or implementing harm reduction strategies to reduce the number of fatal opioid-related overdoses and the occurrence of opioid use disorder among new and at-risk users. 2. Treatment—for example, implementing or expanding access to evidence-based practices for opioid use disorder treatment, such as medication-assisted treatment. 3. Recovery—for example, expanding peer recovery and treatment options that help people with opioid use disorder start recovery and avoid relapse. In the context of the national opioid crisis, the Centers for Disease Control and Prevention (CDC) has identified 220 counties and jurisdictions that are vulnerable to infection or disease outbreak due to injection drug use (hereinafter at-risk counties). Under this grant opportunity, the Agency is prioritizing assistance for rural areas in these at-risk counties. Applications with end-user sites that are in one or more of the at-risk counties will receive additional points in the competitive scoring process. These at-risk counties are listed in section E of this announcement, the FY 2019 DLT Grant Program – Opioid Application Guide (Application Guide), and the CDC website at https://www.cdc.gov/pwid/vulnerable-counties-data.html. The regulation for the DLT Program can be found at 7 CFR part 1734. All applicants should carefully review and prepare their applications according to instructions in the Application Guide and program resources. The Application Guide can be found at https://www.rd.usda.gov/programs-services/distance-learning-telemedicine-grants. Be sure to use the Application Guide that has "Opioid" in the title. Expenses incurred in developing applications will be at the applicant’s own risk.
Version: 2
Modification Comments: Entry initially indicated there was no matching requirement. That was in error, the synopsis has been updated to identify there IS a matching requirement.

Visit the Official Webpage For More Details on Distance Learning and Telemedicine Grants–Opioid.


Please enter your comment!
Please enter your name here